mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.5 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.5 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.5 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |